What it is

GHK-Cu is a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK). GHK is a naturally occurring peptide identified in human plasma and associated with growth-modulating and tissue repair–related biology. When complexed with copper, GHK-Cu has been studied for effects on skin biology, extracellular matrix remodeling, and wound healing–adjacent pathways.

GHK-Cu is widely used in cosmetics and topical formulations, but “peptide” products can vary significantly in stability, delivery, and copper loading.

Why people use it

GHK-Cu is used primarily for skin-related goals such as appearance of aging skin, hair/scalp applications, and general “skin repair” positioning. Interest is driven by mechanistic plausibility around collagen and matrix remodeling plus long-standing cosmetic industry use.

History and origin

GHK was identified as a growth-modulating plasma tripeptide in early work characterizing serum factors that influence cellular growth behavior. Subsequent studies explored its copper-binding properties and the possibility that copper delivery contributes to its biological effects.

How it works

GHK can bind copper with high affinity, and copper is a cofactor relevant to multiple enzymes involved in oxidative stress handling and connective tissue biology. Proposed mechanisms for GHK-Cu include modulation of gene expression programs related to inflammation, antioxidant defenses, and extracellular matrix turnover, as well as effects on fibroblast activity and collagen-related pathways.

It is important to separate mechanism from outcome: even if a peptide changes biomarkers in cell culture, topical penetration, formulation, and real-world clinical endpoints (wrinkles, elasticity, wound outcomes) require independent validation.

Evidence landscape

Evidence spans biochemical studies, cell culture experiments, and animal models. Human evidence exists largely in the cosmetic/topical domain, but many studies vary in formulation and endpoints, making comparisons difficult. Overall, GHK-Cu is better supported for cosmetic plausibility than many gray-market peptides, yet the magnitude of effect in well-controlled human trials is still an area where stronger evidence would be valuable.

Safety reality

Topical GHK-Cu is generally positioned as well tolerated, but irritation and contact reactions can occur with any topical active depending on vehicle and concentration. Systemic use is a different risk category and lacks the kind of safety database expected for drug development. Product quality and correct copper complexation are practical safety variables.

References

Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018). https://pubmed.ncbi.nlm.nih.gov/29986520/

GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (2015). https://pubmed.ncbi.nlm.nih.gov/26236730/